We present the case of a 77-year-old female patient who suffered from severe anaphylaxis during wound care. Allergologic evaluation yielded specific IgE antibodies to chlorhexidine, but anaphylaxis to chlorhexidine was not congruent with the patient history and dermal provocation tests. However, skin prick tests provided evidence for a sensitization to polyhexanide that was further supported by the detection of specific IgE antibodies to polyhexanide, the results of basophil activation tests and IgE inhibition analysis. We presume cross-reactive IgE antibodies binding to both biguanide antiseptics and identified polyhexanide as the likely cause of the anaphylactic reaction. We recognize polyhexanide as an emerging allergen that has to be considered as a cause of anaphylaxis.

Keywords:
Anaphylaxis, Antiseptic, Biguanide, Chlorhexidine, Polyhexanide, Cross-reactivity
1.
Rutkowski K, Wagner A: Chlorhexidine: a new latex? Eur Urol 2015;68:345-347.
2.
Beaudouin E, Kanny G, Morisset M, Renaudin JM, Mertes M, Laxenaire MC, Mouton C, Jacson F, Moneret-Vautrin DA: Immediate hypersensitivity to chlorhexidine: literature review. Eur Ann Allergy Clin Immunol 2004;36:123-126.
3.
Opstrup MS, Malling H-J, Krøigaard M, Mosbech H, Skov PS, Poulsen LK, Garvey LH: Standardized testing with chlorhexidine in perioperative allergy - a large single-centre evaluation. Allergy 2014;69:1390-1396.
4.
Kautz O, Schumann H, Degerbeck F, Venemalm L, Jakob T: Severe anaphylaxis to the antiseptic polyhexanide. Allergy 2010;65:1068-1070.
5.
Olivieri J, Eigenmann PA, Hauser C: Severe anaphylaxis to a new disinfectant: polyhexanide, a chlorhexidine polymer. Schweiz Med Wochenschr 1998;128:1508-1511.
6.
Ferrarini A, Baggi M, Flückiger R, Bianchetti MG: Intraoperative anaphylaxis to a chlorhexdine polymer in childhood. Paediatr Anaesth 2006;16:705.
7.
Ring J, Beyer K, Biedermann T, Bircher A, Duda D, Fischer J, Friedrichs F, Fuchs T, Gieler U, Jakob T, Klimek L, Lange L, Merk HF, Niggemann B, Pfaar O, Przybilla B, Ruëff F, Rietschel E, Schnadt S, Seifert R, Sitter H, Varga EM, Worm M, Brockow K: Guideline for acute therapy and management of anaphylaxis: S2 guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB). Allergo J Int 2014;23:96-112.
8.
Weng M, Zhu M, Chen W, Miao C: Life-threatening anaphylactic shock due to chlorhexidine on the central venous catheter: a case series. Int J Clin Exp Med 2014;7:5930-5936.
9.
Ebo DG, Bridts CH, Hagendorens MM, Aerts NE, De Clerck LS, Stevens WJ: Basophil activation test by flow cytometry: present and future applications in allergology. Cytometry B Clin Cytom 2008;74:201-210.
10.
Odedra KM, Farooque S: Chlorhexidine: an unrecognised cause of anaphylaxis. Postgrad Med J 2014;90:709-714.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.